Is Cannabis Addictive? What the Evidence Says

Yes, cannabis can be addictive. Most people who use it do not become addicted, but a meaningful minority do, and the research is consistent about who is most at risk. The clinical name for it is cannabis use disorder, and it is diagnosed by behavior, not by how much THC is in someone's blood.

What follows covers how common it is, who develops it, how it is diagnosed, and what it means if you hold or are considering a medical certification. The physical symptoms of stopping are a separate subject, covered in the cannabis withdrawal symptoms post. What the evidence supports for cutting back or stopping is covered in quitting cannabis: a clinical guide.

Is Weed Addictive?

Yes, for a minority of people who use it. Estimates of cannabis use disorder among people who use cannabis range from 22 to 30 percent, according to the National Institute on Drug Abuse. The strongest predictor is how often someone uses it.

Two large bodies of evidence sit behind that range. A 2020 systematic review and meta-analysis by Leung and colleagues pooled 21 epidemiological studies and found that 22 percent of people who used cannabis had cannabis use disorder, 13 percent had cannabis abuse, and 13 percent had cannabis dependence. In the United States, the NESARC-III national survey found that 30.6 percent of past-year users met DSM-IV criteria for marijuana use disorder in 2012 to 2013, down from 35.6 percent in 2001 to 2002.

"Addictive" and "addiction" are everyday words. Clinicians use the diagnosis instead, because it describes a pattern of harm rather than a property of a drug.

How Many People Who Use Cannabis Become Addicted?

The answer depends on the denominator, and most of the disagreement online comes from mixing two different ones.

Everyone who has ever tried it. A NESARC analysis of 7,389 lifetime cannabis users estimated the cumulative probability of ever developing cannabis dependence at 8.9 percent. This is the figure behind the familiar "about 1 in 10" estimate.

People using it now. The share is higher, roughly 22 to 30 percent, because current users are weighted toward people who use often. Occasional users tend to stop, and frequent users tend to continue.

The whole population. The 2024 National Survey on Drug Use and Health found that 7.1 percent of people aged 12 or older, about 20.6 million people, had a past-year marijuana use disorder, up from 6.0 percent (16.7 million) in 2021. Among young adults aged 18 to 25 the figure was 15.8 percent.

The NESARC authors made a point about the rising population numbers that is easy to miss. Between 2001 and 2013, the prevalence of marijuana use disorder doubled in the adult population, but the risk among users did not rise. The increase came from more people using cannabis.

Who Is Most at Risk of Cannabis Use Disorder?

Frequency of use comes first. A 2014 review in the New England Journal of Medicine by Volkow and colleagues estimated addiction in about 9 percent of users overall, about 1 in 6 of those who start in adolescence, and 25 to 50 percent of those who use daily. The review rated the evidence for addiction as an adverse effect at a high level of confidence.

The other recognized factors:

• Age at first use. Starting in adolescence roughly doubles the overall estimate. The Leung meta-analysis found the risk of cannabis dependence rose to 33 percent among young people using weekly or daily.
• Duration of use. Longer use at high frequency raises risk, per NIDA.
• Family history of drug use. Listed by NIDA as a contributing factor.
• Co-occurring psychiatric and substance use conditions. The NESARC transition study found psychiatric and dependence comorbidity predicted progression across all four substances it studied.
• Potency. NIDA notes that higher THC concentrations have been associated with a greater likelihood of use progressing to cannabis use disorder.

How Is Cannabis Use Disorder Diagnosed?

By a clinician, using DSM-5. The diagnosis requires a problematic pattern of use causing clinically significant impairment or distress, with two or more of eleven symptoms within a 12-month period. The count sets the severity.

The eleven, as summarized by NIDA:

1. Using larger amounts or for longer than intended
2. Persistent desire or unsuccessful efforts to cut down
3. Spending a lot of time getting, using, or recovering from cannabis
4. Craving
5. Use causing problems at work, school, or home
6. Continued use despite social or relationship problems
7. Giving up important activities to use
8. Use in situations with risk of injury
9. Continued use despite knowing it causes or worsens a physical or psychological problem
10. Tolerance
11. Withdrawal

Severity is graded by count: mild at two or three symptoms, moderate at four or five, severe at six or more.

Two points about that list matter for patients. Tolerance and withdrawal are only two of the eleven, so needing a larger dose is not, on its own, a diagnosis. And most of the criteria describe consequences and loss of control rather than quantity, which is why two people using the same amount can land on opposite sides of the line.

Is Cannabis More Addictive Than Alcohol or Nicotine?

On the probability of becoming dependent after first use, cannabis ranks below the others in the same national sample. The difference shows up clearly in a single study.

The Lopez-Quintero NESARC analysis estimated the cumulative probability of transition from first use to dependence:

The same study found the timing ran the other way. Half of cannabis dependence cases appeared about 5 years after first use, compared with about 13 years for alcohol and 27 years for nicotine. Lower probability does not mean slower onset.

A lower ranking is also not the same as low risk. Cannabis is used by far more people than cocaine, so even a smaller per-person probability produces a large number of cases.

Can Medical Cannabis Patients Develop Cannabis Use Disorder?

Yes. The most direct evidence is a randomized trial, which is rare in this field.

Gilman and colleagues, writing in JAMA Network Open in 2022, randomized 186 adults in the Boston area who were seeking a medical marijuana card. One group could obtain the card immediately. The other was asked to wait 12 weeks. Participants chose their own products, doses, and frequency.

Over the 12 weeks, the immediate group had more cannabis use disorder symptoms and a higher incidence of the disorder: 17.1 percent against 8.6 percent, an adjusted odds ratio of 2.88. The difference was concentrated in participants whose main concern was anxiety or depressive symptoms.

The study was a single site, short, and enrolled people choosing their own retail products, so it does not describe every medical program. What it does establish is that legal access through a certification does not change the underlying risk, and that the risk can appear quickly.

Does Addiction Risk Change What a Certifying Physician Asks?

It should, and the questions are not a judgment. How often you use, how much, how long you have used at that frequency, and whether you have tried to cut back are all routine parts of an evaluation.

A history of cannabis use disorder, or of any substance use disorder, is clinical information the physician weighs. It is not on its own a reason to deny or grant a certification. The same is true of a family history of addiction, which NIDA lists as a risk factor.

Is Cannabis Use Disorder a Qualifying Condition in Florida, Georgia, or Texas?

No. Cannabis use disorder is not a qualifying condition in any of the three state programs, and neither is any other substance use disorder.

• Florida. Fla. Stat. 381.986 lists its enumerated conditions and a comparability provision. No addiction diagnosis appears in the section.
• Georgia. The Medical Cannabis Patient Registry condition list under O.C.G.A. 31-2A-18 does not include any substance use disorder.
• Texas. Occupations Code 169.003, as amended by HB 46 of 2025, does not list any substance use disorder.

The qualifying conditions page shows the full list for each state.

What This Means for Florida, Georgia, and Texas Patients

Be accurate about frequency at your evaluation. Daily use is the single strongest risk factor in every study cited here. A physician can only factor in what you report.

Treat a certification as legal protection, not medical protection. It changes your legal standing under state law. It does not change how THC affects the brain, and the randomized trial above found the risk of cannabis use disorder rose with easier access.

Know the early signs. Using more than you planned, failed attempts to cut down, and giving up activities you used to value are three of the eleven criteria, and they tend to show up before the others.

Tell whoever manages your other prescriptions. Cannabis use disorder often occurs alongside anxiety, depression, and other substance use, and changes in cannabis use belong in that conversation. The cannabis and antidepressants post explains why.

Miracle Leaf® physicians evaluate patients for the Florida, Georgia, and Texas state programs, and your pattern of use is part of every evaluation.

What If You Live Outside Florida, Georgia, and Texas?

The research on cannabis use disorder is not state specific. Only the certification pathway is.

If you live in a state where medical cannabis is legal but Miracle Leaf® has no clinic, the telehealth program covers evaluations in other states where remote certification is permitted. If you are concerned about your own use, the SAMHSA National Helpline at 1-800-662-4357 is free, confidential, and open 24 hours a day.

Sources for Cannabis Addiction and Cannabis Use Disorder

• What is the prevalence and risk of cannabis use disorders among people who use cannabis? A systematic review and meta-analysis. Leung J, Chan GCK, Hides L, Hall WD. Addict Behav. 2020;109:106479. doi:10.1016/j.addbeh.2020.106479. PMID 32485547. Source of the 22 percent, 13 percent, and 13 percent pooled estimates and the 33 percent risk among young regular users.
• Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013. Hasin DS, Saha TD, Kerridge BT, et al. JAMA Psychiatry. 2015;72(12):1235 to 1242. doi:10.1001/jamapsychiatry.2015.1858. PMCID PMC5037576. Source of the 30.6 percent and 35.6 percent figures among users and the finding that risk among users did not increase.
• Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine. Lopez-Quintero C, Perez de los Cobos J, Hasin DS, et al. Drug Alcohol Depend. 2011;115(1-2):120 to 130. doi:10.1016/j.drugalcdep.2010.11.004. PMCID PMC3069146. Source of the 8.9 percent lifetime probability, the cross-substance comparison table, and the time to dependence.
• Adverse health effects of marijuana use. Volkow ND, Baler RD, Compton WM, Weiss SRB. N Engl J Med. 2014;370(23):2219 to 2227. doi:10.1056/NEJMra1402309. PMCID PMC4827335. Source of the 9 percent, 1 in 6, and 25 to 50 percent estimates and the high confidence rating.
• Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults: A Randomized Clinical Trial. Gilman JM, Schuster RM, Potter KW, et al. JAMA Netw Open. 2022;5(3):e222106. doi:10.1001/jamanetworkopen.2022.2106. PMCID PMC8933735. Source of the 17.1 percent and 8.6 percent cannabis use disorder incidence.
• Cannabis (Marijuana) research topic. National Institute on Drug Abuse. Source of the 22 to 30 percent range, the eleven DSM-5 criteria, the severity grading, and the risk factors.
• Key Substance Use and Mental Health Indicators in the United States: Results from the 2024 National Survey on Drug Use and Health. SAMHSA, July 2025. Source of the 7.1 percent, 20.6 million, and 15.8 percent figures.
• Fla. Stat. 381.986, Georgia Medical Cannabis Patient Registry conditions, and Texas HB 46 of 2025 amending Occupations Code 169.003. State qualifying condition lists.

Related Health and Eligibility Resources

• The cannabis withdrawal symptoms post covers the symptoms of stopping and how long they last.
• The quitting cannabis: a clinical guide post covers what the evidence supports for cutting back or stopping.
• The is weed a depressant, stimulant, or hallucinogen post covers how cannabis is classified pharmacologically.
• The cannabis and alcohol post covers combined use, which is common among people with either use disorder.
• The qualifying conditions page covers eligibility in all three state programs.

Talk to a Physician About Your Cannabis Use

A frank conversation about how often you use is part of a good evaluation, not a barrier to one. Call (833) LEGAL-MJ or contact us online to book. Evaluation pricing is on the pricing page, and the clinicians who review this content are listed on the editorial team page.

Disclaimer

This post is informational and is not medical advice. It summarizes population research on cannabis use disorder and cannot tell you whether you have it; only a clinician who knows your history can make that assessment. The prevalence figures describe study populations measured with different diagnostic editions (DSM-IV and DSM-5) and different sampling frames, which is why they differ. The randomized trial cited was a single-site, 12-week study of people choosing their own retail products. Cannabis use disorder is not a qualifying condition in Florida, Georgia, or Texas. Do not start, stop, or change a prescribed medication based on this article. If you are in crisis or thinking about self-harm, call or text the 988 Suicide and Crisis Lifeline.